Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guam Technology Journal.
Press releases published on September 8, 2025
TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
GlobeNewswire
·
September 8, 2025
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has commenced in a Phase 3 trial evaluating subcutaneous BRIUMVI (ublituximab-xiiy), the company’s anti-CD20 monoclonal antibody, in people …
Angitia Biopharmaceuticals Presents First-in-Human Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025
GlobeNewswire
·
September 8, 2025
• Clinical data demonstrated administration of AGA2115 drove dose-dependent increases in bone mineral density • The Company and collaborators also presented data from non-human primate and mouse models WESTLAKE VILLAGE, Calif., Sept. 08, 2025 (GLOBE …
Bitcoin Bancorp (OTC: BULT) Retained by NASDAQ-Listed Sadot Group (NASDAQ: SDOT) to Develop Institutional Bitcoin Treasury Strategy
GlobeNewswire
·
September 8, 2025
LAS VEGAS, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Bitcoin Bancorp. (OTC: BULT) (“Bitcoin Bancorp” or the “Company”), formerly Bullet Blockchain, Inc., a leading advisor in Bitcoin treasury strategies and institutional digital asset management, today announced …
Kraig Biocraft Laboratories Appoints Kenneth Le as Managing Director of Prodigy Silk
GlobeNewswire
·
September 8, 2025
ANN ARBOR, Mich., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, is happy to announce the appointment of Mr. Kenneth Le as Managing Director of its …
Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
GlobeNewswire
·
September 8, 2025
-- Recommendation that trial escalate to next dose level of 8mg tablet -- -- Initial interim clinical data from first two cohorts expected in Q1 2026 -- MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the …
Attralus Presents New Data on Its Pan-Amyloid Diagnostic Imaging Candidates at ASNC 2025
GlobeNewswire
·
September 8, 2025
124I-evuzamitide, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis of cardiac amyloidosis in patients suspected of or diagnosed with cardiac amyloidosis in ATTR, AL, and other rare types of …
Vertex to Present at Goldman Sachs Communacopia + Technology Conference
GlobeNewswire
·
September 8, 2025
KING OF PRUSSIA, Pa., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a global provider of tax technology solutions, today announced that David DeStefano, Chief Executive Officer, and John Schwab, Chief Financial Officer, will participate in …
IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants
GlobeNewswire
·
September 8, 2025
iMDx’s ClinicalTrials.gov listing now names 10 leading transplant centers, up from 5 previously GraftAssureDx remains on track for FDA submission by end of 2025, commercial launch in 2026 NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Insight …
Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025
GlobeNewswire
·
September 8, 2025
Tonmya was approved by FDA on August 15, 2025 for the treatment of fibromyalgia and is the first new FDA approved treatment for fibromyalgia in over 15 years Two pivotal Phase 3 studies demonstrated Tonmya significantly reduced fibromyalgia pain compared …
SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent
GlobeNewswire
·
September 8, 2025
Significant Development in the Estimated $30 Billion Global Infection-Prevention Market SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that the United States …
Ocular Therapeutix™ to Host Investor Day on September 30, 2025
GlobeNewswire
·
September 8, 2025
Company to highlight ongoing AXPAXLI™ wet AMD registrational program, strategy and next steps in NPDR and DME, and global commercial opportunity for AXPAXLI Event to feature global retinal disease experts Dr. Arshad M. Khanani MD, MA, FASRS; Professor …
TPE : la trésorerie tombe à son plus bas niveau de l’année
GlobeNewswire
·
September 8, 2025
Axonaut dévoile les résultats de son Observatoire de la trésorerie des TPE et PME françaises pour le deuxième trimestre 2025. Les chiffres confirment un contexte économique dégradé pour les petites entreprises. Au deuxième trimestre 2025, la trésorerie se …
Customs Assured Realizes 30% Productivity Gain by Streamlining Customs Declarations with Descartes and AiDock
GlobeNewswire
·
September 8, 2025
LONDON and ATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that U.K.-based customs consultancy Customs Assured is streamlining …
Esker et PwC Poland s’associent pour accélérer la transformation digitale de la fonction finance
GlobeNewswire
·
September 8, 2025
LYON, France — 8 septembre 2025 — Esker, pionnière des solutions d’Agentic AI dédiées à l’Office of the CFO, annonce aujourd’hui une collaboration avec l’équipe Finance Transformation de PwC Poland. L’objectif : proposer aux clients en Pologne, dans la …
Dataprana Signs $10 Million Deal with Bitmain for New Immersion Units
GlobeNewswire
·
September 8, 2025
MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dataprana, Inc. (“Dataprana”) has signed a $10 million agreement with Bitmain Technologies Delaware Ltd. (“Bitmain”) for the purchase of over 3,000 Antminer S21 Immersion units, which will be hosted at its mining …
Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies
GlobeNewswire
·
September 8, 2025
In separate cat and birch allergen-challenge trials, single doses of allergen-specific antibody blockers significantly reduced allergy symptoms compared to placebo Data from these trials will support further Phase 3 development TARRYTOWN, N.Y., Sept. 08, …
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 8, 2025
HUNTSVILLE, AL, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Steve Ledger, Chief …
Rapport Announces Positive Topline Results from Phase 2a Clinical Trial of RAP-219 in Patients with Focal Onset Seizures
GlobeNewswire
·
September 8, 2025
Trial met primary long episode endpoints with high statistical significance, and RAP-219 was generally well tolerated Patients achieved 77.8% reduction in clinical seizures (p=0.01), with 24% achieving seizure freedom for the 8-week treatment period (p<0. …
XerpaAI Partners with Sherpa Guides to Support Historic Autumn Everest Summit Attempt
GlobeNewswire
·
September 8, 2025
TOKYO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- XerpaAI, the world’s first AI Growth Agent (AGA), is proud to announce its sponsorship and partnership with legendary Sherpa guides for a historic climb of Mount Everest during this autumn season — a feat that has …
Al Salam Bank Signs Strategic Deal with Denodo and NAIB IT to Advance Data Management and AI Initiatives
GlobeNewswire
·
September 8, 2025
MANAMA, Kingdom of Bahrain, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Al Salam Bank has signed a strategic deal with Denodo, a global leader in data management, AWS, and NAIB IT, a Bahrain-based systems integrator known for delivering high-impact technology …